Sep 2, 2022 | Drug Costs, Featured
By Surabhi Dangi-Garimella, Ph.D. March-in rights have been invoked again, this time with the support of Senators Elizabeth Warren (D-Mass.) and Angus King (I-Maine), and Congressman Lloyd Doggett (D-Texas). March-in rights, a provision of the Bayh-Dole regulations,...
Read more
May 23, 2022 | Drug Costs, Featured, Podcast
On this episode of the podcast, Terry and Bob discuss a new effort by entrepreneur Mark Cuban to deliver less expensive medications to patients. They also explain the ongoing baby formula shortage plaguing the country and point out how the industry’s...
Read more
Dec 15, 2021 | Drug Costs, Letters Supported
On behalf of the estimated 50 million Americans with autoimmune and immune-mediated diseases, the undersigned 64 organizations write to you regarding the importance of the Orphan Drug Tax Credit (ODTC) for people and families living with autoimmune disease and urge...
Read more
Dec 13, 2021 | Drug Costs, Featured
By Surabhi Dangi-Garimella, PhD In a bid to ensure access to medications for low-income and uninsured patient populations, the 340B drug discount program was launched in 1992. Designed primarily with safety-net hospitals in mind—meaning hospitals that serve a...
Read more
Oct 26, 2021 | Drug Costs, Featured, Podcast
On this episode of the podcast, Terry and Bob discuss the Build Back Better reconciliation bill currently being debated in Congress and highlight its drug pricing components. They explain how the highly-touted cost savings in the bill won’t actually help...
Read more
Sep 28, 2021 | Drug Costs
On September 9, 2021, the Biden Administration released a long-awaited plan aimed at reducing prescription drug prices. What’s in the Plan? At a high level, the plan would: Allow the Secretary of Health and Human Services (HHS) to negotiate Medicare Part B...
Read more
